Patents by Inventor Pernilla Sorme

Pernilla Sorme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adamantyl Iminocarbonyl-Substituted Pyrimidines As Inhibitors Of 11-Beta-HSD1 826
    Publication number: 20110092526
    Abstract: A compound of formula (I): and pharmaceutically-acceptable salts thereof, wherein the variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are also described herein.
    Type: Application
    Filed: October 19, 2010
    Publication date: April 21, 2011
    Applicant: ASTRAZENECA AB
    Inventors: Stuart Norman Lile Bennett, Frederick Woolf Goldberg, Andrew Leach, Paul Robert Owen Whittamore, Pernilla Sörme
  • New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087
    Publication number: 20090306133
    Abstract: The present invention relates to Acetyl Coenzyme A Carboxylase (ACC) inhibitors according to formula (I), or an enantiomer thereof, or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, E, L, Z and n are as defined herein, to processes for preparing such compounds, to pharmaceutical compositions containing them, to the use of such inhibitors and to methods for their therapeutic use, particularly in the treatments of obesity and diabetes mellitus.
    Type: Application
    Filed: December 19, 2008
    Publication date: December 10, 2009
    Applicant: ASTRAZENECA AB
    Inventors: David Blomberg, Anders Holmen, Petra Johannesson, Pernilla Sorme, Pernilla Stahlberg, Kay Brickmann, Volker Schnecke, Eric Wellner, Ragnar Hovland, Asa Mansson, Alleyn Plowright
  • SUBSTITUTED PYRIMIDIN-5-CARBOXAMIDES 281
    Publication number: 20090264401
    Abstract: A compound of formula (I): and pharmaceutically-acceptable salts thereof wherein the variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are also described.
    Type: Application
    Filed: April 21, 2009
    Publication date: October 22, 2009
    Applicant: AstraZeneca AB
    Inventors: Adrian Liam GILL, Andrew Leach, Martin Packer, James Stewart Scott, Pernilla Sorme, John Gibbin Swales, Paul Robert Owen Whittamore
  • Inhibitors against galectins
    Patent number: 7230096
    Abstract: The present invention relates to novel compounds, the use of said compounds as a medicament as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to receptors in a mammal. Said galectin is preferably a galectin 3.
    Type: Grant
    Filed: January 21, 2002
    Date of Patent: June 12, 2007
    Inventors: Ulf Nilsson, Hakon Leffler, Pernilla Sörme
  • Inhibitors against galectins
    Publication number: 20040147730
    Abstract: The present invention relates to novel compounds, the use of said compounds as a medicament as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to receptors in a mammal. Said galectin is preferably a galectin 3.
    Type: Application
    Filed: January 14, 2004
    Publication date: July 29, 2004
    Inventors: Ulf Nilsson, Hakon Leffler, Pernilla Sorme